Monday, Apr 23, 2018
One of America's Great Newspapers ~ Toledo, Ohio


FDA panel OKs nonprescription sale of fat-blocking pill

WASHINGTON A Food and Drug Administration panel of doctors and scientists voted today to recommend that the regulatory agency approve over-the-counter sales of a weight-loss pill now sold only with a prescription.

GlaxoSmithKline Consumer Healthcare still needs final FDA approval before it can sell the nonprescription version of orlistat, a drug already marketed in prescription form as Xenical, to overweight adults as use as a weight-loss aid.

The FDA approved the prescription version of the fat-blocking pill made by Roche in 1999.

A joint FDA advisory committee voted 11-2 to recommend approval late Monday following a daylong hearing. The agency usually follows the recommendations of its outside panels of experts.

Currently, the FDA has not approved any nonprescription weight-loss drugs for sale.

Read more in later editions of The Blade and

Click to comment

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem?

Temporibus autem quibusdam et aut officiis debitis aut rerum necessitatibus saepe eveniet.

Copyright © 2018 Toledo Blade

To Top

Fetching stories…